Andrew Witty — Board Member Accountability Profile
Category: Private Citizen — Corporate Executive Director Role: CEO & Director, UnitedHealth Group Inc. (UNH) Board Tenure: 2021 – present Committee Memberships: None (CEO capacity) Profile Type: Board Member Accountability — Anchor B (Documented Organizational Leadership)
Basis for Inclusion: Andrew Witty holds documented executive and governance authority as CEO and director of UnitedHealth Group Inc. As operating CEO, Witty bears primary operational responsibility for UnitedHealth’s regulatory engagement, government contract relationships, and political strategy. UnitedHealth’s Optum segment is one of the largest federal government healthcare contractors. The Change Healthcare data breach in 2024 — which disrupted payments across U.S. healthcare — and subsequent litigation occurred under Witty’s tenure. This profile documents the factual governance relationship, not the subject’s personal political views.
Subject Classification: Private Citizen / Corporate Executive Director. Board membership and executive role are matters of public record (SEC filings, proxy statements). This profile documents only the governance role and its connection to documented corporate political activity.
Biographical Overview
Andrew Witty (born March 6, 1964) has been CEO of UnitedHealth Group since February 2021 and was previously CEO of Optum, UnitedHealth’s technology and services segment, beginning 2019. Before UnitedHealth, he served as CEO of GlaxoSmithKline (GSK) from 2008 to 2017, where he managed one of the world’s largest pharmaceutical companies through drug pricing controversies, bribery settlements in China, and manufacturing challenges. He was knighted by Queen Elizabeth II in 2012 for services to the pharmaceutical industry.
Witty’s tenure at UnitedHealth has been marked by the 2024 cyberattack on Change Healthcare — a UnitedHealth subsidiary — that was the largest healthcare data breach in U.S. history. The attack disrupted payment processing across tens of thousands of healthcare providers and prompted Congressional hearings. He testified before both the Senate Finance Committee and the Energy & Commerce Committee in May 2024 regarding the breach.
He holds a B.A. in Business Studies from the University of Nottingham.
Board Role and Governance Authority
- Company: UnitedHealth Group Inc. (NYSE: UNH)
- Board tenure: 2021 – present
- Executive role: CEO (since February 2021)
Parent Corporate Donor Profile
This profile is a governance-accountability companion to the UnitedHealth Group corporate donor profile, which documents the corporation’s political spending and regulatory relationships under the Trump administration.
Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@patriot.university with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.
Investigative trail pointers (public records)
Education only — verify independently. Absence of hits is not proof.
| Channel | Starting points |
|---|---|
| Federal courts | CourtListener / PACER party and attorney searches (spelling variants) |
| Campaign finance | FEC + OpenSecrets for committees and donors tied to documented roles |
| Corporate / LLC | State secretary of state; OpenCorporates for cross-border shells from reporting |
| Sanctions / PEP | OpenSanctions when international business context is already sourced |
| Contracts / grants | USAspending.gov for named entities from investigations |
Use public-records-research-specialist, corporate-intelligence-investigator, and public-corruption-ombudsman evidence tiers.
Sources
- UnitedHealth Group Inc. DEF 14A Proxy Statement, filed April 21, 2025; SEC EDGAR (CIK 731766)